84
Participants
Start Date
June 30, 2008
Primary Completion Date
January 31, 2010
Study Completion Date
June 30, 2010
Leuprolide acetate 11.25 mg
Two intramuscular injections of leuprolide acetate for depot suspension 11.25 mg administered 3 mo apart.
Leuprolide acetate 30 mg
Two intramuscular injections of leuprolide acetate for depot suspension 30 mg administered 3 mo apart.
Site Reference ID/Investigator# 8763, Hershey
Site Reference ID/Investigator# 8764, Jacksonville
Site Reference ID/Investigator# 17621, Pensacola
Site Reference ID/Investigator# 8771, Gainesville
Site Reference ID/Investigator# 8765, Birmingham
Site Reference ID/Investigator# 8752, Indianapolis
Site Reference ID/Investigator# 17341, Saint Paul
Site Reference ID/Investigator# 8768, Minneapolis
Site Reference ID/Investigator# 8759, Kansas City
Site Reference ID/Investigator# 8766, Shreveport
Site Reference ID/Investigator# 8750, Oklahoma City
Site Reference ID/Investigator# 8760, Tulsa
Site Reference ID/Investigator# 8749, Greenwood Village
Site Reference ID/Investigator# 8754, Salt Lake City
Site Reference ID/Investigator# 8756, Los Angeles
Site Reference ID/Investigator# 11522, Long Beach
Site Reference ID/Investigator# 8755, San Diego
Site Reference ID/Investigator# 8761, San Diego
Site Reference ID/Investigator# 8762, Seattle
Site Reference ID/Investigator# 8753, Seattle
Site Reference ID/Investigator# 8772, Stanford
Site Reference ID/Investigator# 17922, Bayamón
Site Reference ID/Investigator# 17923, Ponce
Site Reference ID/Investigator# 18242, San Juan
Site Reference ID/Investigator# 19661, San Juan
Lead Sponsor
Abbott
INDUSTRY